Table 1.
ID and Exponent 1 or 0 |
Age | Sex | KI67 | TTP (day) |
OS (day) |
Surgery | Diagnostic and Clinical Evolution | 1p/19q Status |
|
---|---|---|---|---|---|---|---|---|---|
1 P1 | 40 | F | 5% | 894 | 5212 | 1 | Oligodendroglioma Mid aggressive |
1p-/19q- | |
2 | Oligodendroglioma | 1p-/19q- | |||||||
1 P2 | 40 | F | ++ | 350 | 2172 | 1 | Oligodendroglioma Mid aggressive |
1p-/19q- | |
2 | Oligodendroglioma | 1p-/19q- | |||||||
1 P3 | 42 | M | 15% | 95 | 721 | 1 | Oligodendroglioma aggressive | 1p- | |
2 | Oligodendroglioma | 1p- | |||||||
1 P4 | P4a | 29 | M | ++ | 930 | 1748 | 1 | Oligodendroglioma indolent | 1p-/19q- Polysomic |
2 | Oligodendroglioma | 1p-/19q- Polysomic | |||||||
P4b | ++ | 197 | 3 | Oligodendroglioma | 19q- | ||||
4 | Oligoastrocytoma | 19q- | |||||||
1 P5 | 33 | F | >40% | 335 | 4242 | 1 | Oligodendroglioma Mid aggressive |
1p-/19q- Polysomic |
|
2 | Oligodendroglioma | 1p-/19q- Polysomic |
|||||||
0 P6 | 55 | F | 5% | 1058 | 4582 | 1 | Oligodendroglioma indolent | 1p-/19q- | |
2 | Oligodendroglioma | 1p-/19q- | |||||||
0 P7 | 37 | M | >25% | 437 | 3141 | 1 | Oligodendroglioma indolent | 1p-/19q- | |
2 | Anaplastic oligodendroglioma | 1p-/19q- | |||||||
1 P8 | 47 | F | Hetero-geneous till 60% | 246 | 500 | 1 | Anaplastic oligodendroglioma Invasive |
19q- Polysomic | |
2 | Anaplastic oligodendroglioma | 19q- Polysomic | |||||||
1 P9 | 79 | M | >30% | 232 | 1103 | 1 | Anaplastic oligodendroglioma Aggressive |
1p-/19q- Polysomic | |
2 | Anaplastic oligodendroglioma | 1p- Polysomic | |||||||
1 P10 | 46 | F | Nd | 119 | 735 | 1 | Oligodendroglioma aggressive | 1p- Polysomic | |
2 | Oligodendroglioma | 1p- Polysomic |
0: alive; 1: dead; TTP: days between first surgery (diagnosis) to second surgery; OS: days between first surgery (diagnosis) to end point. ++: mild or moderate expression